As much of California begins allowing businesses to reopen amid improved coronavirus conditions, a farming region bordering Mexico is experiencing a spike in hospitalizations that some believe is driven by American citizens ...
May 21, 2020
0
1
Getting personal protective equipment to the frontlines while America fights COVID-19 has more twists and turns than it may seem, but thinking about the supply chain from a disaster recovery perspective can help, a University ...
Apr 20, 2020
0
0
Academics at Royal Holloway have developed a new genetic medicine that has been given the go ahead by the U.S Food and Drug Association (FDA) to be prescribed globally to a subset of patients with Duchenne muscular dystrophy ...
Feb 25, 2020
0
19
Griffith University's Institute for Glycomics and Melbourne-based company Paradigm Biopharmaceuticals Limited (ASX: PAR) have reported impressive results from their Phase 2A clinical trials of a new drug candidate to treat ...
Dec 13, 2019
0
0
New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense bleeding events during endovascular related procedures by using sensors to detect relative changes in tissue bioimpedance. ...
May 21, 2019
0
1
(HealthDay)—On average, hospitals mark up drugs by 479 percent of their cost, according to a report from The Moran Company, commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Sep 20, 2018
1
3
St. Jude Children's Research Hospital in Tennessee has announced a $100 million plan to expand a global outreach program in hopes of improving access and quality of medical care for many children with cancer around the world.
May 24, 2018
0
2
A Purdue University-affiliated startup has devised a way to map arteries in the roof of a person's mouth to help avoid complications and improve outcomes in oral surgery.
Apr 11, 2018
0
3
US drugstore chain CVS Health announced Sunday it would buy medical insurer Aetna for about $69 billion, in a move that would create a new giant in the healthcare sector.
Dec 4, 2017
0
0
New preclinical research suggests the potential utility of BPN14770, a selective PDE4D inhibitor currently under development by Tetra Discovery Partners as a prospective treatment for memory and cognitive problems associated ...
Nov 7, 2017
0
6
